CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Repros Therapeutics Inc.  (RPRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

RPRX's Revenue Year on Year Growth by Quarter and Year

Repros Therapeutics's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
RPRX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.01 0.01 -
III Quarter September - 0.01 - -
II Quarter June - 0.02 - -
I Quarter March 0.01 0.02 - -
FY   0.01 0.06 0.01 -

Financial Statements
Repros Therapeutics's first quarter 2017 Revenue $ 0.01 millions RPRX's Income Statement
Repros Therapeutics's first quarter 2016 Revenue $ 0.02 millions Quarterly RPRX's Income Statement
RPRX's Growth by Division See RPRX's Growth by Segment

RPRX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 0 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March -65 % - - -
FY   - 500 % - -



RPRX Revenue Growth Comment
Repros Therapeutics Inc. reported drop in Revenue in the first quarter by -65% to $ 0.01 millions, from the same quarter in 2016.
The fall in the first quarter Repros Therapeutics Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 283.01%.

Looking into first quarter results within Biotechnology & Drugs industry 79 other companies have achieved higher Revenue growth. While Repros Therapeutics Inc.' s Revenue drop of -65% ranks overall at the positon no. 3523 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #80
Healthcare Sector #450
S&P 500 #3523
Revenue Y/Y Growth Statistics
High Average Low
1600 % 283.01 % -99.8 %
(Mar 31 2016)   (Dec 31 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RPRX's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RPRX's Competitors
Revenue Growth for Repros Therapeutics's Suppliers
Revenue Growth for RPRX's Customers

You may also want to know
RPRX's Annual Growth Rates RPRX's Profitability Ratios RPRX's Asset Turnover Ratio RPRX's Dividend Growth
RPRX's Roe RPRX's Valuation Ratios RPRX's Financial Strength Ratios RPRX's Dividend Payout Ratio
RPRX's Roa RPRX's Inventory Turnover Ratio RPRX's Growth Rates RPRX's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Utah Medical Products Inc -0.41 %$ -0.408 millions
Livanova Plc -0.65 %$ -0.650 millions
Tearlab Corp -0.98 %$ -0.975 millions
Parexel International Corp -1.01 %$ -1.014 millions
Alliqua Biomedical, Inc. -1.06 %$ -1.055 millions
Spark Therapeutics, Inc. -1.10 %$ -1.099 millions
Amgen Inc. -1.14 %$ -1.140 millions
Biolase, Inc -1.24 %$ -1.235 millions
Ligand Pharmaceuticals Inc -1.29 %$ -1.285 millions
Seattle Genetics Inc -1.82 %$ -1.821 millions
Reliv International Inc -1.98 %$ -1.984 millions
Adaptimmune Therapeutics Plc -2.09 %$ -2.090 millions
Wright Medical Group N.v. -2.12 %$ -2.119 millions
Oncomed Pharmaceuticals Inc -2.16 %$ -2.157 millions
Prothena Corp Plc -2.26 %$ -2.264 millions
Antares Pharma, Inc. -2.53 %$ -2.527 millions
Integrated Biopharma Inc -2.89 %$ -2.889 millions
Allied Healthcare Products Inc -2.93 %$ -2.930 millions
Becton Dickinson & Co -3.20 %$ -3.195 millions
Infusystem Holdings, Inc -3.50 %$ -3.498 millions
Brookdale Senior Living Inc. -3.67 %$ -3.673 millions
Kindred Healthcare, Inc -3.79 %$ -3.785 millions
Tenet Healthcare Corp -4.13 %$ -4.133 millions
Chembio Diagnostics, Inc. -4.18 %$ -4.180 millions
Progenics Pharmaceuticals Inc -4.20 %$ -4.204 millions
Cas Medical Systems Inc -4.23 %$ -4.228 millions
Amphastar Pharmaceuticals, Inc. -4.54 %$ -4.541 millions
Strata Skin Sciences, Inc. -4.57 %$ -4.567 millions
Birner Dental Management Services Inc -4.69 %$ -4.690 millions
Fibrogen Inc -4.92 %$ -4.918 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
PACV's Profile
Stock Price
PACV's Financials
PACV's Expectations
Business Description
Fundamentals
Charts & Quotes
PACV's News
Suppliers
PACV's Competitors
Customers & Markets
Economic Indicators
PACV's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com